IL-31 Antikörper (AA 21-120)
-
- Target Alle IL-31 (IL31) Antikörper anzeigen
- IL-31 (IL31) (Interleukin 31 (IL31))
-
Bindungsspezifität
- AA 21-120
-
Reaktivität
- Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser IL-31 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Kreuzreaktivität
- Maus
- Homologie
- Rat
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from mouse IL-31
- Isotyp
- IgG
- Top Product
- Discover our top product IL31 Primärantikörper
-
anti-Interleukin 31 (IL31) (AA 21-70) antibody
IL31 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 31 (IL31) (AA 13-40), (N-Term) antibodyIL31 Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB22575 unconjugated
anti-Interleukin 31 (IL31) (AA 28-154) antibodyIL31 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 31 (IL31) (AA 31-130) antibodyIL31 Reaktivität: Human ELISA, ICC, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 31 (IL31) antibodyIL31 Reaktivität: Human, Maus WB, IHC, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 31 (IL31) (AA 19-49), (N-Term) antibodyIL31 Reaktivität: Human, Maus WB, FACS, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 31 (IL31) (AA 55-183) antibodyIL31 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Maus Monoclonal A3 unconjugated
anti-Interleukin 31 (IL31) antibodyIL31 Reaktivität: Human ELISA Wirt: Maus Monoclonal SB118b unconjugated
anti-Interleukin 31 (IL31) antibody (Biotin)IL31 Reaktivität: Human ELISA Wirt: Maus Monoclonal SB118b Biotin
anti-Interleukin 31 (IL31) (AA 24-164) antibodyIL31 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 5G9 unconjugated
-
- Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- IL-31 (IL31) (Interleukin 31 (IL31))
- Andere Bezeichnung
- IL-31 (IL31 Produkte)
- Synonyme
- IL-31 antikoerper, 1700013B14Rik antikoerper, IL31 antikoerper, interleukin 31 antikoerper, IL31 antikoerper, Il31 antikoerper
- Hintergrund
-
Synonyms: Interleukin-31, 1700013B14RIK, IL31, interleukin-31 precursor.
Background: Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia and skin lesions, and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development.
- Gen-ID
- 76399
-
